You are logged on as Guest.
RegisterLoginShopping cart (Empty)
 United States

Andrastin A

Farnesyltransferase inhibitor
 
ALX-350-418-MC25 0.25 mg 77.00 USD
 
ALX-350-418-M001 1 mg 232.00 USD
 
Farnesyltransferase inhibitor with antitumor properties. Inhibits the efflux of anticancer drugs from multidrug-resistant cancer cells. Secondary fungal metabolite from Penicillium and Aspergillus.

Product Specification

Formula:C28H38O7
 
MW:486.6
 
Purity:≥95% (HPLC)
 
Appearance:White to off-white powder.
 
CAS:174232-42-9
 
Source/Host:Isolated from Aspergillus fumigatus.
 
Solubility:Soluble in DMSO, methanol, chloroform or ethyl acetate; insoluble in hexane or water.
 
Long Term Storage:-20°C
 
Hazard:HARMFUL.
 
350-418
Please mouse over
350-418

Product Literature References

Mycotoxins and other secondary metabolites produced in vitro by Penicillium paneum Frisvad and Penicillium roqueforti Thom isolated from baled grass silage in Ireland: M. O'Brien, et al.; J. Agric. Food Chem. 54, 9268 (2006), Abstract;
Andrastin A and barceloneic acid metabolites, protein farnesyl transferase inhibitors from Penicillium albocoremium: chemotaxonomic significance and pathological implications: D.P. Overy, et al.; Mycol. Res. 109, 1243 (2005), Abstract;
Andrastins A-D, Penicillium roqueforti Metabolites consistently produced in blue-mold-ripened cheese: K.F. Nielsen, et al.; J. Agric. Food Chem. 53, 2908 (2005), Abstract;
Modeling of binding modes and inhibition mechanism of some natural ligands of farnesyl transferase using molecular docking: A. Pedretti, et al.; J. Med. Chem. 45, 1460 (2002), Abstract;
Enhancement of drug accumulation by andrastin A produced by Penicillium sp. FO-3929 in vincristine-resistant KB cells: M.C. Rho, et al.; J. Antibiot. (Tokyo) 51, 68 (1998), Abstract; Full Text
Andrastins A-C, new protein farnesyltransferase inhibitors produced by Penicillium sp. FO-3929. II. Structure elucidation and biosynthesis: R. Uchida, et al.; J. Antibiot. (Tokyo) 49, 418 (1996), Abstract;
©2010 Enzo Life Sciences, Inc.,